Avrobio Inc reported 32.62M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Akebia Therapeutics AKBA:US $ 103.64M 28.61M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Applied Genetic Technologies AGTC:US $ 16.42M 2.14M
Bluebird Bio BLUE:US $ 239.63M 8.68M
Epizyme EPZM:US $ 69.34M 1.9M
Gilead Sciences GILD:US $ 3579M 392M
Intercept Pharmaceuticals ICPT:US $ 82.54M 13.28M
Karyopharm Therapeutics KPTI:US $ 81.5M 9.85M
Macrogenics MGNX:US $ 68.65M 2.39M
Pfizer PFE:US $ 16447M 3384M
Sangamo Biosciences SGMO:US $ 77M 427K
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
Takeda 4502:JP 747.39B 46.34B